S. H. Seo et al. / Tetrahedron Letters 48 (2007) 6839–6844
6843
8. Seo, S. H.; Chang, J. Y. Chem. Mater. 2005, 17,
3249.
9. Seo, S. H.; Tew, G. N.; Chang, J. Y. Soft Mat. 2006, 10,
886.
10. Breslow, R. Acc. Chem. Rec. 1991, 24, 317.
11. Schneider, F. Angew. Chem., Int. Ed. Engl. 1978, 17,
583.
12. Katrusiak, A. J. Mol. Struct. 1999, 474, 125.
13. Suisse, J.-M.; Bellemin-Laponnaz, S.; Douce, L.; Maisse-
Franc¸ois, A.; Welter, R. Tetrahedron Lett. 2005, 46,
4303.
31.7, 29.0, 28.7, 22.9, 20.0, 14.5. IR (KBr pellet, cmꢀ1):
3141, 3011, 2920, 2850, 2654, 2593, 1728, 1508, 1449, 1336,
1199, 979. Compound 2: Yield 0.92 g (55%). 1H NMR
(300 MHz, DMSO): d 12.82 (s, 1H, NH), 8.03, 7.88 (s, 2H,
imidazole ring protons), 7.10, 6.95 (dd, 4H, ArH), 3.96 (t,
2H, ArOCH2), 1.73–1.28 (m, 16H, CH2), 0.85 (t, 3H,
CH3). 13C NMR (75 MHz, DMSO): d 164.4, 139.1, 133.6,
120.5, 117.2, 85.3, 75.1, 74.6, 65.6, 32.2, 29.6, 29.5, 29.3,
28.7, 23.1, 20.0, 14.5. IR (KBr pellet, cmꢀ1): 3141, 3011,
2920, 2851, 2654, 2593, 1729, 1508, 1447, 1338, 1199, 977.
Compound 3: Yield 0.93 g (52%). 1H NMR (300 MHz,
DMSO): d 12.80 (s, 3H, NH), 8.05, 7.88 (s, 2H, imidazole
ring protons), 7.09, 6.96 (dd, 4H, ArH), 3.96 (t, 2H,
14. Kumar, S.; Pal, S. K. Tetrahedron Lett. 2005, 46, 2607.
15. Dobbs, W.; Douce, L.; Allouche, L.; Louati, A.; Malbose,
F.; Welter, R. New J. Chem. 2006, 30, 528.
ArOCH2), 1.70-1.25 (m, 20H, CH2), 0.86 (t, 3H, CH3). 13
C
16. Bradley, A. E.; Hardacre, C.; Holbrey, J. D.; Johnston, S.;
McMath, S. E. J.; Nieuwenhuyzen, M. Chem. Mater.
2002, 14, 629.
17. Cheng, X. H.; Diele, S.; Tschierske, C. Angew. Chem., Int.
Ed. 2000, 39, 592.
NMR (75 MHz, DMSO): d 164.2, 138.9, 133.4, 120.3,
117.0, 85.0, 74.8, 74.4, 65.4, 32.1, 29.8, 29.7, 29.5, 29.3,
29.1, 28.5, 22.9, 19.8, 14.3. IR (KBr pellet, cmꢀ1): 3152,
3010, 2917, 2851, 2654, 2585, 1733, 1507, 1446, 1342, 1199,
982.
18. Yang, D.; Armitage, B.; Marder, S. R. Angew. Chem., Int.
Ed. 2004, 43, 4402.
19. Kato, T.; Matsuoka, T.; Nishii, M.; Kamikawa, Y.;
Kanie, K.; Nishimura, T.; Yashima, E.; Ujiie, S. Angew.
Chem., Int. Ed. 2004, 43, 1969.
20. Ungar, G.; Zeng, X. Soft Mat. 2005, 1, 95.
21. Yeardley, D. J. P.; Ungar, G.; Percec, V.; Holerca, M. N.;
Johansson, G. J. Am. Chem. Soc. 2000, 122, 1684.
22. Cheng, X.; Das, M. K.; Diele, S.; Tschierske, C. Langmuir
2002, 18, 6521.
23. Lee, M.; Cho, B.-K.; Kim, H.; Zin, W.-C. Angew. Chem.,
Int. Ed. 1998, 37, 638.
24. Yoshio, M.; Mukai, T.; Ohno, H.; Kato, T. J. Am. Chem.
Soc. 2004, 126, 994.
25. Palmans, A. R. A.; Vekemans, J. A. J. M.; Hikmet, R. A.;
Fischer, H.; Meijer, E. W. Adv. Mater. 1998, 10, 873.
26. Hulvat, J. F.; Sofos, M.; Tajima, K.; Stupp, S. I. J. Am.
Chem. Soc. 2005, 127, 366.
33. Compound 4: This compound was prepared according to
our previous report.8 To a solution of compound 3 (0.2 g,
0.49 mmol) and sodium hydride (0.015 g, 0.54 mmol) in
DMF (15 mL) was added 1-bromoethane (0.15 mL,
1.47 mmol) under nitrogen. The reaction mixture was
stirred for 24 h at 90 °C. After removal of precipitates by
filtration, the filtrates were concentrated to dryness by
evaporation under reduced pressure. The product was
isolated by column chromatography on silica gel (EA/n-
hexane = 2/1); yield 0.19 g (90%). 1H NMR (300 MHz,
DMSO): d 7.88, 7.58 (s, 2H, imidazole ring protons), 7.10,
6.90 (dd, 4H, ArH), 4.07 (q, 2H, N–CH2), 3.94 (t, 2H,
ArOCH2), 2.17 (t, 3H, N–CH2CH3), 1.75–1.27 (m, 20H,
CH2), 0.88 (t, 3H, CH3). 13C NMR (75 MHz, DMSO): d
164.5, 139.3, 133.4, 120.4, 117.2, 85.1, 74.8, 74.4, 65.4,
39.9, 32.1, 29.8, 29.7, 29.5, 29.3, 29.1, 28.5, 22.9, 19.8, 16.4,
14.3. IR (KBr pellet, cmꢀ1): 3101, 2923, 2852, 1740, 1506,
1386, 1245, 1191, 1171, 1080, 966.
27. Chang, J. Y.; Baik, J. H.; Lee, C. B.; Han, M. J.; Hong,
S.-K. J. Am. Chem. Soc. 1997, 119, 3197.
28. Percec, V.; Ahn, C.-H.; Bera, T. K.; Ungar, G.; Yeardley,
D. J. P. Chem. Eur. J. 1999, 5, 1070.
29. Hwang, I. H.; Lee, S. J.; Chang, J. Y. J. Polym. Sci.
Polym. Chem. Ed. 2003, 41, 1881.
30. Lee, H.-K.; Lee, H.; Ko, Y. H.; Chang, Y. J.; Oh, N.-K.;
Zin, W.-C.; Kim, K. Angew. Chem., Int. Ed. 2001, 40,
2669.
34. Compounds 5–7: These compounds were prepared accord-
ing to our previous report.9 A typical procedure is as
follows. To a solution of 4-hydroxyphenyl 3,4,5-tris(n-
octan-1-yloxy)benzoate9 (1 g, 1.7 mmol) in DMF (50 mL)
was added sodium hydride (0.05 g, 2.0 mmol). After
stirring for 1 h at room temperature, 4-chlorocarbonyl
imidazole (1.24 g, 7.4 mmol) was added. The solution was
stirred for 24 h at 90 °C. After filtration and evaporation,
the product (compound 5) was isolated by column
chromatography on silica gel (THF/n-hexane = 2/1 v/v)
and further purified by recrystallization from THF/n-
hexane; (65 % yield). 1H NMR (300 MHz, CDCl3): d 7.92,
7.84 (s, 2H, imidazole ring protons), 7.41 (s, 2H, ArH),
7.27 (dd, 4H, ArH), 4.05 (t, 6H, ArOCH2), 1.29–1.86 (m,
36H, CH2), 0.88 (t, 9H, CH3). 13C NMR (75 MHz,
CDCl3): d 165.47, 161.30, 153.22, 148.69, 148.28, 143.41,
138.10, 123.80, 123.07, 122.98, 108.87, 73.87, 69.53, 32.11,
32.03, 31.12, 30.57, 29.72, 29.56, 29.53, 29.49, 26.31, 26.26,
22.90, 22.87, 13.80. IR (KBr pellet, cmꢀ1): 3113, 3078,
2925, 2663, 2598, 1732, 1504, 1336, 1178, 1127, 976.
31. Shu, W.; Valiyaveettil, S. Chem. Commun. 2002, 1350.
32. Compounds 1–3: These compounds were prepared accord-
ing to our previous report.8 A typical procedure is as
follows: 4-Imidazole carboxylic acid (1 g, 9 mmol) in
benzene (10 mL) was stirred at room temperature, and
then thionyl chloride (10 mL) dissolved in benzene
(10 mL) was added slowly. The mixture was refluxed for
10 h. After evaporation, the product (4-chlorocarbonyl-
imidazole) was dried and used for the next reaction
without further purification. To a solution of 40-octyloxy
phenol (1 g, 4.40 mmol) and sodium hydride (0.13 g,
4.84 mmol) in DMF (50 mL) was added 4-chlorocarbonyl-
imidazole (0.83 g, 4.84 mmol) under nitrogen. The reac-
tion mixture was stirred for 24 h at 90 °C. After removal
of precipitates by filtration, the filtrates were concentrated
to dryness by evaporation under reduced pressure. The
product (compound 1) was isolated by column chroma-
tography on silica gel (THF/n-hexane = 3/1); yield 0.93 g
(60%). 1H NMR (300 MHz, DMSO): d = 12.82 (s, 1H,
NH), 8.03, 7.88 (s, 2H, imidazole ring protons), 7.10, 6.95
(dd, 4H, ArH), 3.96 (t, 2H, ArOCH2), 1.73–1.28 (m, 12H,
CH2), 0.85 (t, 3H, CH3). 13C NMR (75 MHz, DMSO): d
164.4, 139.1, 133.6, 120.5, 117.2, 85.3, 75.1, 74.6, 65.6,
1
Compound 6: H NMR (300 MHz, CDCl3): d 7.92, 7.84
(s, 2H, imidazole ring protons), 7.41 (s, 2H, ArH), 7.26
(dd, 4H, ArH), 4.05 (t, 6H, ArOCH2), 1.29–1.86 (m, 48H,
CH2), 0.87 (t, 9H, CH3). 13C NMR (75 MHz, CDCl3): d
165.44, 160.82, 153.22, 148.70, 148.22, 143.42, 138.08,
123.78, 123.03, 122.96, 108.86, 73.85, 69.53, 32.15, 32.12,
30.56, 29.94, 29.90, 29.88, 29.84, 29.79, 29.61, 29.55, 29.52,
26.30, 26.27, 22.90, 14.31. IR (KBr pellet, cmꢀ1): 3113,
3068, 2852, 2666, 2600, 1735, 1502, 1338, 1180, 1122, 976.
1
Compound 7: H NMR (300 MHz, CDCl3): d 7.92, 7.84
(s, 2H, imidazole ring protons), 7.41 (s, 2H, ArH), 7.26
(dd, 4H, ArH), 4.05 (t, 6H, ArOCH2), 1.29–1.86 (m, 60H,